Pepti · Catalog · Cartalax

Cartilage bioregulator · research-use

Cartalax (AED) OEM supply.

Research-use Ala-Glu-Asp tripeptide bioregulator, manufactured to ≥98% HPLC with batch COA and mass-spec identity — private-label and bulk from a China-based OEM.

Cartalax lyophilized vial
CartalaxHPLC ≥ 98%MS confirmed20mg

Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.

CompoundCartalax
ClassLongevity, cognitive & bioregulators
Molecular formulaC12H19N3O8
Molecular weight333.29 g/mol
SequenceAla-Glu-Asp
FormLyophilized powder, sterile glass vial
Purity target≥ 98% by HPLC
Vial formats20mg
DocumentationCOA + HPLC + MS, batch lot file where available
Distribution scopeResearch use, worldwide
StorageStore lyophilized powder sealed at -20°C, protected from light and moisture; short-term room-temperature transit is tolerated. After reconstitution, keep refrigerated at 2–8°C and use within the validated stability window. For laboratory research use only.

MOQ & lead time

TierQuantityLead time
Sample lotFrom 50 vials3–7 days
Production lot200–1,000 vials10–14 days
OEM repeat1,000+ vials14–18 days, scheduled

Cartalax is a synthetic Ala-Glu-Asp (AED) tripeptide bioregulator of the Khavinson short-peptide class, studied in preclinical cartilage and connective-tissue models and supplied by Pepti as a research-use, private-label OEM product.

Documentation

Batch documentation support for Cartalax lots.

COA / HPLC / MS document support where available. Distribution scope confirmed before invoicing.

HPLC purity

Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.

MS identity

Mass spectrometry identity confirmation against the Cartalax reference profile.

Lot traceability

Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.

FAQ

Cartalax — frequently asked by B2B buyers.

What is Cartalax and in what format does Pepti supply it?

Cartalax is a synthetic Ala-Glu-Asp (AED) tripeptide bioregulator of the Khavinson short-peptide class. Pepti supplies it as a lyophilized white powder in sealed vials for laboratory research use, in a 20 mg vial format with a 50-vial minimum order, and offers private-label / OEM options.

What documentation ships with each batch?

Each batch is accompanied by a Certificate of Analysis (COA) reporting HPLC purity and mass-spectrometry (MS) identity confirmation. Additional documentation such as TDS and safety data can be provided to qualified B2B accounts on request.

What purity does Pepti provide?

Cartalax is manufactured to a typical purity of ≥98% by HPLC. The exact figure for each lot is stated on the batch-specific COA, and tighter specifications can be quoted on RFQ.

Do you offer private-label / OEM and custom quantities?

Yes. Pepti is a China-based OEM and private-label manufacturer. Custom fill weights, vial labeling, kitting, and bulk volumes beyond the catalog 20 mg / 50-vial MOQ are available under RFQ.

Is a CAS number available for Cartalax?

The exact all-L Ala-Glu-Asp tripeptide is catalogued in PubChem (CID 87815447) but has no assigned CAS registry number, and some CAS values circulating online actually map to unrelated compounds. Batch identity is confirmed by mass spec, and any regulatory identifiers are confirmed on RFQ.

WhatsApp us